Iveric Bio announces FDA approval for IZERVAY™️️
Congratulations to Iveric Bio for their FDA approval for IZERVAY™️️, a new treatment for...
read Details
Congratulations to Amicus Therapeutics for their European Commission approval for Pombiliti™ in patients with Late-Onset Pompe Disease. We applaud Amicus and are proud to have contributed to their cold chain over the last seven years with full validation master planning and transport simulation.
Congratulations to Iveric Bio for their FDA approval for IZERVAY™️️, a new treatment for...
read DetailsCongratulations to Incyte on their FDA approval for Zynyz™, a treatment for adults with metastatic...
read DetailsThe team at Acadia Pharmaceuticals Inc. announced FDA Approval on their drug Daybue, for...
read Details